OGXI: Can anyone post recent examples of Oncology drugs that did not meet the interim efficacy hurdle (75% of planned events), but did meet the final efficacy requirement?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.